Skip to content
AnalystLens
Back to ROIVBalance Sheet

Roivant Sciences Long-Term Debt 2021-2025 | ROIV

Annual FY2021–FY2024 · quarterly through Q1 FY2025

Latest annual · FY2024

$430.6M

+14.7%YoY vs FY2023Source: 10-KFY2024

From $170.3M in FY2021 to $430.6M in FY2024: 2.5× in 3 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY25$312M−19.0%Not reportedNot reportedNot reported
FY24$385M+0.4%$389M+3.6%$403M+7.5%$431M+14.7%
FY23$384M+105.9%$376M+88.2%$375M+83.8%$376M+78.8%
FY22$186M$200M$204M$210M+23.3%
FY21Not reportedNot reportedNot reported$170M

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionGrowing
CAGR

+36.2%

FY2021
$170.3M
FY2024
$430.6M

3 years selected · on the chart

Long-Term Debt History

Year-over-year comparison from 10-K annual reports

  1. $430.6M
YoY changeLargest recent move+78.8%in FY23Latest +14.7%

Long-Term Debt, period by period

PeriodValueChangeSource
FY2024$430.6M+14.7%10-K
FY2023$375.5M+78.8%10-K
FY2022$210.0M+23.3%10-K
FY2021$170.3M—10-K

What is long-term debt?

Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.

What is Roivant Sciences's current long-term debt?

Roivant Sciences (ROIV) annual long-term debt for 2024 was $430.6M, a 14.67% increase from 2023. Roivant Sciences long-term debt for the quarter ending June 30, 2024 was $311.7M.

What was Roivant Sciences's long-term debt in 2023?

Roivant Sciences annual long-term debt for 2023 was $375.5M, a 78.80% increase from 2022.

What was Roivant Sciences's long-term debt in 2022?

Roivant Sciences annual long-term debt for 2022 was $210.0M, a 23.34% increase from 2021.

What is Roivant Sciences's 3-year long-term debt CAGR?

Roivant Sciences long-term debt grew at a compound annual growth rate (CAGR) of 36.24% from FY2021 to FY2024, going from $170.3M to $430.6M over 3 years.

Company
Roivant Sciences
Ticker
ROIV
Sector
Healthcare
Industry
Pharmaceutical Preparations